Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg, Joseph F Merola, Knut Schäkel, Luis Puig, Patrick D Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, Christopher E M Griffiths

Fingerprint

Dive into the research topics of 'Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences